Memantine LEK
Ülke: Avrupa Birliği
Dil: Letonca
Kaynak: EMA (European Medicines Agency)
Bilgilendirme broşürü
(PIL)
16-11-2020
Ürün özellikleri
(SPC)
16-11-2020
Kamu Değerlendirme Raporu
(PAR)
29-04-2013
Aktif bileşen:
memantīna hidrohlorīds
Mevcut itibaren:
Pharmathen S.A.
ATC kodu:
N06DX01
INN (International Adı):
memantine
Terapötik grubu:
Psychoanaleptics, , Citas anti-demenci zāles
Terapötik alanı:
Alcheimera slimība
Terapötik endikasyonlar:
Pacientiem ar vidēji smagu vai smagu Alcheimera slimību ārstēšana.
Ürün özeti:
Revision: 5
Yetkilendirme durumu:
Autorizēts
Yetkilendirme tarihi:
2013-04-21
Bilgilendirme broşürü
Skip to main content [European Medicines Agency]
Menu *
EMA WEBSITE TEMPORARILY UNAVAILABLE
This website is currently unavailable due to essential maintenance.
EMERGENCY CONTACT DETAILS
To report a potentially serious problem with a centrally authorised
medicine, call our product emergency hotline on +31 (0)88 781 7600.
To report a product quality defect, including a suspected defect, of a
centrally authorised medicine that could result in a recall or
abnormal restriction on supply, marketing or manufacturing
authorisation holders can call +31 (0)65 008 9457 outside business
hours.
The details of your call may be documented, including personal data if
you provide them (such as your name, contact details and nature of the
issue raised), in accordance with our privacy statement. You can
consult our privacy statement at
https://www.ema.europa.eu/en/about-us/legal/general-privacy-statement
[/en/about-us/legal/general-privacy-statement] once the website is
back online.
RSS feed Twitter YouTube LinkedIn
© 1995-2020 European Medicines Agency
European Union agencies network [European Union agencies network]
An agency of the European Union [European Union flag]
Belgenin tamamını okuyun
Ürün özellikleri
Skip to main content [European Medicines Agency]
Menu *
EMA WEBSITE TEMPORARILY UNAVAILABLE
This website is currently unavailable due to essential maintenance.
EMERGENCY CONTACT DETAILS
To report a potentially serious problem with a centrally authorised
medicine, call our product emergency hotline on +31 (0)88 781 7600.
To report a product quality defect, including a suspected defect, of a
centrally authorised medicine that could result in a recall or
abnormal restriction on supply, marketing or manufacturing
authorisation holders can call +31 (0)65 008 9457 outside business
hours.
The details of your call may be documented, including personal data if
you provide them (such as your name, contact details and nature of the
issue raised), in accordance with our privacy statement. You can
consult our privacy statement at
https://www.ema.europa.eu/en/about-us/legal/general-privacy-statement
[/en/about-us/legal/general-privacy-statement] once the website is
back online.
RSS feed Twitter YouTube LinkedIn
© 1995-2020 European Medicines Agency
European Union agencies network [European Union agencies network]
An agency of the European Union [European Union flag]
Belgenin tamamını okuyun
